Alzheimer’s drug sparks emotional battle as FDA nears deadline on whether to approve: If cleared, the drug would be the first for slowing cognitive decline, but critics say the data does not prove it works

Alzheimer’s drug sparks emotional battle as FDA nears deadline on whether to approve: If cleared, the drug would be the first for slowing cognitive decline, but critics say the data does not prove it works

Alzheimer’s drug sparks emotional battle as FDA nears deadline on whether to approve: If cleared, the drug would be the first for slowing cognitive decline, but critics say the data does not prove it works

submitted by /u/DoremusJessup
[link] [comments]

Comments